7 Marijuana Stocks That Look Way Too Expensive Here

Marijuana stocks moved higher after November’s U.S. elections on renewed hopes that federal legalization could become reality. Although legalization has happened in a patchwork manner on a state-by-state basis, federal action remains elusive. Senate majority leader Chuck Schumer and other senators have stated that they will push legislation this year. Broader sentiment is that now is the tipping point to end federal prohibition. The cannabis sector had moved higher on such hopes.  Yet, marijuana stocks themselves have yet to uphold their promise of being the next ‘it’ sector. Revenues haven’t been as high as pundits predicted, and profitability has been elusive.  Since early February, the sector has lost that post-election momentum. The Global X Cannabis ETF (NASDAQ:POTX), with its 26 pot-stock portfolio, is down 41.7% since Feb. 10. The result are cannabis names that could look enticing on price alone. However, more analysis is needed. Fortunately, we’ve done some of that for you, dear reader, on the following seven marijuana stocks: HEXO (NYSE:HEXO) Canopy Growth (NASDAQ:CGC) Tilray (NASDAQ:TLRY) Cronos Group (NASDAQ:CRON) Aurora Cannabis (NYSE:ACB) OrganiGram (NASDAQ:OGI) Sundial Growers (NASDAQ:SNDL)